Chronic inhibition of nitric oxide synthase activity by N G-nitro-l-arginine induces nitric oxide synthase expression in the developing rat cerebellum

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Studies on chronic inhibition of nitric oxide synthase (NOS) in the CNS suggest a plastic change in nitric oxide (NO) synthesis in areas related to motor control, which might protect the animal from the functional and behavioral consequences of NO deficiency. In the present study, the acute and chronic effect of the substrate analogue inhibitor NG-nitro-l-arginine (l-NNA) was examined on NO production, NO-sensitive cyclic guanosine monophosphate (cGMP) levels and the expression of NOS isoforms in the developing rat cerebellum. Acute intraperitoneal administration of the inhibitor (5-200 mg/kg) to 21-day-old rats reduced NOS activity and NO concentration dose dependently by 70-90% and the tissue cGMP level by 60-80%. By contrast, chronic application of l-NNA between postnatal days 4-21 diminished the total NOS activity and NO concentration only by 30%, and the tissue cGMP level by 10-50%. Chronic treatment of 10 mg/kg l-NNA induced neuronal (n)NOS expression in granule cells, as revealed by in situ hybridization, NADPH-diaphorase histochemistry and Western-blot, but it had no significant influence on tissue cGMP level or on layer formation of the cerebellum. However, a higher concentration (50 mg/kg) of l-NNA decreased the intensity of the NADPH-diaphorase reaction in granule cells, significantly reduced cGMP production, and retarded layer formation and induced inducible (i)NOS expression & activity in glial cells. Treatments did not affect endothelial (e)NOS expression. The administration of the biologically inactive isomer D-NNA (50 mg/kg) or saline was ineffective. The present findings suggest the existence of a concentration-dependent compensatory mechanism against experimentally-induced cronich inhibition of NOS, including nNOS or iNOS up-regulation, which might maintain a steady-state NO level in the developing cerebellum.

Original languageEnglish
Pages (from-to)605-615
Number of pages11
JournalNeurochemistry International
Volume60
Issue number6
DOIs
Publication statusPublished - May 2012

Fingerprint

Nitric Oxide Synthase
Cerebellum
Arginine
Nitric Oxide
Cyclic GMP
NADPH Dehydrogenase
Nitric Oxide Synthase Type I
Nitric Oxide Synthase Type III
Nitric Oxide Synthase Type II
Neuroglia
In Situ Hybridization
Protein Isoforms
Up-Regulation
Western Blotting

Keywords

  • Cerebellum
  • Cyclic guanosine monophosphate
  • Development
  • Inhibition
  • Nitric oxide synthase
  • Nitroarginine

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Cell Biology

Cite this

@article{f6e4f93798604382a035c1878f37c487,
title = "Chronic inhibition of nitric oxide synthase activity by N G-nitro-l-arginine induces nitric oxide synthase expression in the developing rat cerebellum",
abstract = "Studies on chronic inhibition of nitric oxide synthase (NOS) in the CNS suggest a plastic change in nitric oxide (NO) synthesis in areas related to motor control, which might protect the animal from the functional and behavioral consequences of NO deficiency. In the present study, the acute and chronic effect of the substrate analogue inhibitor NG-nitro-l-arginine (l-NNA) was examined on NO production, NO-sensitive cyclic guanosine monophosphate (cGMP) levels and the expression of NOS isoforms in the developing rat cerebellum. Acute intraperitoneal administration of the inhibitor (5-200 mg/kg) to 21-day-old rats reduced NOS activity and NO concentration dose dependently by 70-90{\%} and the tissue cGMP level by 60-80{\%}. By contrast, chronic application of l-NNA between postnatal days 4-21 diminished the total NOS activity and NO concentration only by 30{\%}, and the tissue cGMP level by 10-50{\%}. Chronic treatment of 10 mg/kg l-NNA induced neuronal (n)NOS expression in granule cells, as revealed by in situ hybridization, NADPH-diaphorase histochemistry and Western-blot, but it had no significant influence on tissue cGMP level or on layer formation of the cerebellum. However, a higher concentration (50 mg/kg) of l-NNA decreased the intensity of the NADPH-diaphorase reaction in granule cells, significantly reduced cGMP production, and retarded layer formation and induced inducible (i)NOS expression & activity in glial cells. Treatments did not affect endothelial (e)NOS expression. The administration of the biologically inactive isomer D-NNA (50 mg/kg) or saline was ineffective. The present findings suggest the existence of a concentration-dependent compensatory mechanism against experimentally-induced cronich inhibition of NOS, including nNOS or iNOS up-regulation, which might maintain a steady-state NO level in the developing cerebellum.",
keywords = "Cerebellum, Cyclic guanosine monophosphate, Development, Inhibition, Nitric oxide synthase, Nitroarginine",
author = "Z. Serfőző and Be{\'a}ta Lontay and Z. Kukor and F. Erdődi",
year = "2012",
month = "5",
doi = "10.1016/j.neuint.2012.02.019",
language = "English",
volume = "60",
pages = "605--615",
journal = "Neurochemistry International",
issn = "0197-0186",
publisher = "Elsevier Limited",
number = "6",

}

TY - JOUR

T1 - Chronic inhibition of nitric oxide synthase activity by N G-nitro-l-arginine induces nitric oxide synthase expression in the developing rat cerebellum

AU - Serfőző, Z.

AU - Lontay, Beáta

AU - Kukor, Z.

AU - Erdődi, F.

PY - 2012/5

Y1 - 2012/5

N2 - Studies on chronic inhibition of nitric oxide synthase (NOS) in the CNS suggest a plastic change in nitric oxide (NO) synthesis in areas related to motor control, which might protect the animal from the functional and behavioral consequences of NO deficiency. In the present study, the acute and chronic effect of the substrate analogue inhibitor NG-nitro-l-arginine (l-NNA) was examined on NO production, NO-sensitive cyclic guanosine monophosphate (cGMP) levels and the expression of NOS isoforms in the developing rat cerebellum. Acute intraperitoneal administration of the inhibitor (5-200 mg/kg) to 21-day-old rats reduced NOS activity and NO concentration dose dependently by 70-90% and the tissue cGMP level by 60-80%. By contrast, chronic application of l-NNA between postnatal days 4-21 diminished the total NOS activity and NO concentration only by 30%, and the tissue cGMP level by 10-50%. Chronic treatment of 10 mg/kg l-NNA induced neuronal (n)NOS expression in granule cells, as revealed by in situ hybridization, NADPH-diaphorase histochemistry and Western-blot, but it had no significant influence on tissue cGMP level or on layer formation of the cerebellum. However, a higher concentration (50 mg/kg) of l-NNA decreased the intensity of the NADPH-diaphorase reaction in granule cells, significantly reduced cGMP production, and retarded layer formation and induced inducible (i)NOS expression & activity in glial cells. Treatments did not affect endothelial (e)NOS expression. The administration of the biologically inactive isomer D-NNA (50 mg/kg) or saline was ineffective. The present findings suggest the existence of a concentration-dependent compensatory mechanism against experimentally-induced cronich inhibition of NOS, including nNOS or iNOS up-regulation, which might maintain a steady-state NO level in the developing cerebellum.

AB - Studies on chronic inhibition of nitric oxide synthase (NOS) in the CNS suggest a plastic change in nitric oxide (NO) synthesis in areas related to motor control, which might protect the animal from the functional and behavioral consequences of NO deficiency. In the present study, the acute and chronic effect of the substrate analogue inhibitor NG-nitro-l-arginine (l-NNA) was examined on NO production, NO-sensitive cyclic guanosine monophosphate (cGMP) levels and the expression of NOS isoforms in the developing rat cerebellum. Acute intraperitoneal administration of the inhibitor (5-200 mg/kg) to 21-day-old rats reduced NOS activity and NO concentration dose dependently by 70-90% and the tissue cGMP level by 60-80%. By contrast, chronic application of l-NNA between postnatal days 4-21 diminished the total NOS activity and NO concentration only by 30%, and the tissue cGMP level by 10-50%. Chronic treatment of 10 mg/kg l-NNA induced neuronal (n)NOS expression in granule cells, as revealed by in situ hybridization, NADPH-diaphorase histochemistry and Western-blot, but it had no significant influence on tissue cGMP level or on layer formation of the cerebellum. However, a higher concentration (50 mg/kg) of l-NNA decreased the intensity of the NADPH-diaphorase reaction in granule cells, significantly reduced cGMP production, and retarded layer formation and induced inducible (i)NOS expression & activity in glial cells. Treatments did not affect endothelial (e)NOS expression. The administration of the biologically inactive isomer D-NNA (50 mg/kg) or saline was ineffective. The present findings suggest the existence of a concentration-dependent compensatory mechanism against experimentally-induced cronich inhibition of NOS, including nNOS or iNOS up-regulation, which might maintain a steady-state NO level in the developing cerebellum.

KW - Cerebellum

KW - Cyclic guanosine monophosphate

KW - Development

KW - Inhibition

KW - Nitric oxide synthase

KW - Nitroarginine

UR - http://www.scopus.com/inward/record.url?scp=84860494076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860494076&partnerID=8YFLogxK

U2 - 10.1016/j.neuint.2012.02.019

DO - 10.1016/j.neuint.2012.02.019

M3 - Article

C2 - 22391324

AN - SCOPUS:84860494076

VL - 60

SP - 605

EP - 615

JO - Neurochemistry International

JF - Neurochemistry International

SN - 0197-0186

IS - 6

ER -